Loading…
Quality Supplement Manufacturing, Inc. received a warning for adulterated dietary supplements that failed to comply with Current Good Manufacturing Practice (CGMP) regulations under 21 CFR Part 111. During a June 2022 inspection, the FDA identified serious violations including the company's failure to establish adequate product specifications for identity and purity of finished batches, specifically noting deficiencies in specifications for multiple dietary supplement products. The violations indicated that the company's products were prepared, packed, or held under conditions that did not meet federal CGMP requirements, rendering them adulterated under the Federal Food, Drug, and Cosmetic Act.